Article

Evaluation of drug-specific multigene markers to predict aromatase inhibitor efficacy in advanced breast cancer: a cohort study from Danish Breast Cancer Cooperative Group

2019-08-29

Abstract excerpt

<title>Abstract</title> <p>Background Even with positive oestrogen receptor (ER+) status some advanced breast cancer (ABC) patients fail to benefit from endocrine therapy (ET). A method that previously predicted other drugs in various cancers was evaluated. Here multigene markers based on aromatase inhibitor (AI) effect in vitro were used for prediction of AI benefit in ER+ ABC patients. Simultaneously effects of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b511e17f-9345-5f66-a2af-b695f798ec40
DOI: 10.21203/rs.2.10981/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of drug-specific multigene markers to predict aromatase inhibitor efficacy in advanced breast cancer: a cohort study from Danish Breast Cancer Cooperative GroupDOI 10.21203/rs.2.10981/v1Read

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersSemantic proximity Read

An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor ResistanceSemantic proximity Read

Patient-Derived Xenograft-Guided Prediction of Chemotherapy Response in Triple-Negative Breast CancerSemantic proximity Read

Understanding tumour growth variability in patient-derived breast cancer xenograft models identifies early responders and biomarkers of resistance to PARP inhibitionSemantic proximity Read

Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approachSemantic proximity Read

Gene isoforms as expression-based biomarkers predictive of drug response <i>in vitro</i>Semantic proximity Read

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Semantic proximity Read

Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancerSemantic proximity Read

CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.Semantic proximity Read

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSemantic proximity Read

Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to LetrozoleSemantic proximity Read